Fuan Pharmaceutical (Group) Co., Ltd.

SZSE:300194 Stock Report

Market Cap: CN¥4.5b

Fuan Pharmaceutical (Group) Balance Sheet Health

Financial Health criteria checks 5/6

Fuan Pharmaceutical (Group) has a total shareholder equity of CN¥4.3B and total debt of CN¥716.0M, which brings its debt-to-equity ratio to 16.6%. Its total assets and total liabilities are CN¥6.0B and CN¥1.7B respectively. Fuan Pharmaceutical (Group)'s EBIT is CN¥258.1M making its interest coverage ratio -3. It has cash and short-term investments of CN¥953.7M.

Key information

16.6%

Debt to equity ratio

CN¥716.03m

Debt

Interest coverage ratio-3x
CashCN¥953.73m
EquityCN¥4.32b
Total liabilitiesCN¥1.68b
Total assetsCN¥6.00b

Recent financial health updates

Recent updates

There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings

Aug 23
There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings

Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?

Jun 07
Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?

Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

May 02
Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Apr 03
Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Financial Position Analysis

Short Term Liabilities: 300194's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.4B).

Long Term Liabilities: 300194's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥322.4M).


Debt to Equity History and Analysis

Debt Level: 300194 has more cash than its total debt.

Reducing Debt: 300194's debt to equity ratio has increased from 1% to 16.6% over the past 5 years.

Debt Coverage: 300194's debt is well covered by operating cash flow (73.6%).

Interest Coverage: 300194 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies